UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Vascular comorbidities in the onset and progression of multiple sclerosis

Journal of the neurological sciences, 2014-12, Vol.347 (1), p.23-33

2014

Volltextzugriff (PDF)

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

Journal of neurology, 2009-04, Vol.256 (4), p.577-585

2009

Volltextzugriff (PDF)

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

Multiple sclerosis, 2020-12, Vol.26 (14), p.1816-1821

2020

Volltextzugriff (PDF)

Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016

Journal of neurology, neurosurgery and psychiatry, 2018-01, Vol.89 (1), p.34

2018

Volltextzugriff (PDF)

The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology

Journal of the neurological sciences, 2015-01, Vol.348 (1), p.126-131

2015

Volltextzugriff (PDF)

Polymorphism in the serotonin transporter gene polymorphisms (5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosis

Multiple sclerosis, 2019-05, Vol.25 (6), p.848-855

2019

Volltextzugriff (PDF)

Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2019-06, Vol.90 (6), p.636

2019

Volltextzugriff (PDF)

Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis

Neuroepidemiology, 2008-01, Vol.31 (4), p.271-279

2008

Volltextzugriff (PDF)

Latitudinal variation in incidence and type of first central nervous system demyelinating events

Multiple sclerosis, 2010-04, Vol.16 (4), p.398-405

2010

Volltextzugriff (PDF)

An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event

Journal of neurology, neurosurgery and psychiatry, 2017-05, Vol.88 (5), p.395

2017

Volltextzugriff (PDF)

Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: Gene-environment interaction

Annals of neurology, 2010-02, Vol.67 (2), p.261-265

2010

Volltextzugriff (PDF)

What affects your MS? Responses to an anonymous, Internet-based epidemiological survey

Multiple sclerosis, 2004-04, Vol.10 (2), p.202-211

2004

Volltextzugriff (PDF)

Stressful life events and the risk of initial central nervous system demyelination

Multiple sclerosis, 2017-06, Vol.23 (7), p.1000-1007

2017

Volltextzugriff (PDF)

Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2014-04, Vol.85 (4), p.399-404

2014

Volltextzugriff (PDF)

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2011-10, Vol.82 (10), p.1132-1141

2011

Volltextzugriff (PDF)

The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults

Multiple sclerosis and related disorders, 2018-01, Vol.19, p.161-165

2018

Volltextzugriff (PDF)

Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data

Multiple sclerosis, 2020-10, Vol.26 (11), p.1315-1328

2020

Volltextzugriff (PDF)

Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype

Multiple sclerosis, 2021-07, Vol.27 (8), p.1262-1275

2021

Volltextzugriff (PDF)

Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis

Multiple sclerosis, 2019-06, Vol.25 (7), p.994-1004

2019

Volltextzugriff (PDF)

The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study

Multiple sclerosis, 2024-06, Vol.30 (7), p.877-887

2024

Volltextzugriff (PDF)

Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis

Multiple sclerosis, 2020-10, Vol.26 (12), p.1550-1559

2020

Volltextzugriff (PDF)

Vitamin D deficiency is an etiological factor for MS – Commentary

Multiple sclerosis, 2019-04, Vol.25 (5), p.641-643

2019

Volltextzugriff (PDF)

Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis

Journal of neurology, 2021-02, Vol.268 (2), p.602-612

2021

Volltextzugriff (PDF)

Development and psychometric properties of the Multiple Sclerosis Knowledge Assessment Scale: Rasch analysis of a novel tool for evaluating MS knowledge

Multiple sclerosis, 2021-04, Vol.27 (5), p.767-777

2021

Volltextzugriff (PDF)

Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia

Multiple sclerosis, 2020-04, Vol.26 (4), p.411-420

2020

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

ThemaClinical Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(108)

Sprache

Englisch
(108)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Vascular comorbidities in the onset and progression of multiple sclerosis

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016

The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology

Polymorphism in the serotonin transporter gene polymorphisms (5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosis

Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis

Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis

Latitudinal variation in incidence and type of first central nervous system demyelinating events

An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event

Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: Gene-environment interaction

What affects your MS? Responses to an anonymous, Internet-based epidemiological survey

Stressful life events and the risk of initial central nervous system demyelination

Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults

Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data

Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype

Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis

The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study

Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis

Vitamin D deficiency is an etiological factor for MS – Commentary

Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis

Development and psychometric properties of the Multiple Sclerosis Knowledge Assessment Scale: Rasch analysis of a novel tool for evaluating MS knowledge

Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia

Aktive Filter

Suchergebnisse filtern